VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $10,225,000 | -17.2% | 713,550 | 0.0% | 2.16% | +21.8% |
Q2 2017 | $12,344,000 | +56.8% | 713,550 | 0.0% | 1.77% | +63.8% |
Q1 2017 | $7,870,000 | -24.0% | 713,550 | 0.0% | 1.08% | -43.0% |
Q4 2016 | $10,361,000 | -60.3% | 713,550 | -32.9% | 1.90% | -60.2% |
Q3 2016 | $26,098,000 | +21.9% | 1,063,057 | 0.0% | 4.76% | +63.6% |
Q2 2016 | $21,410,000 | -23.5% | 1,063,057 | -0.1% | 2.91% | +4.2% |
Q1 2016 | $27,974,000 | -59.4% | 1,063,657 | +56.9% | 2.79% | -41.9% |
Q4 2015 | $68,919,000 | +85.8% | 678,000 | +226.0% | 4.81% | +83.4% |
Q3 2015 | $37,103,000 | +14.9% | 208,000 | +43.1% | 2.62% | +43.5% |
Q2 2015 | $32,280,000 | +485.2% | 145,306 | +423.2% | 1.83% | +438.9% |
Q1 2015 | $5,516,000 | -63.4% | 27,770 | -73.6% | 0.34% | -57.7% |
Q4 2014 | $15,051,000 | +465.6% | 105,172 | +418.5% | 0.80% | +464.1% |
Q3 2014 | $2,661,000 | -92.9% | 20,284 | -93.1% | 0.14% | -93.9% |
Q2 2014 | $37,239,000 | +1100.5% | 295,267 | +1154.9% | 2.33% | +704.5% |
Q1 2014 | $3,102,000 | -35.9% | 23,529 | -42.9% | 0.29% | -18.8% |
Q4 2013 | $4,838,000 | – | 41,209 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |